Connect Biopharma Holdings Limited

$0.91- (-)1Y −47.62%

As of Oct 16, 2026 close

Market cap: $56.99M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $0.85$3.82
Volume (live): -
Avg. volume (3M): 7.47M

Connect Biopharma Holdings Limited (CNTB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Connect Biopharma Holdings Limited stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy

Based on 7 unique analysts

(9 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$6.86

+656.92% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest CNTB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 12, 2026	Unknown Analyst	Leerink Partners	Maintains	Buy	$4.00
Oct 8, 2026	Brandon Folkes	HC Wainwright	Reiterates	Buy	$7.00
Oct 2, 2026	Brandon Folkes	HC Wainwright	Reiterates	Buy	$7.00
Oct 1, 2026	Edward Nash	Canaccord Genuity	Reiterates	Buy	$6.00
Sep 30, 2026	Thomas Flaten	Lake Street	Maintains	Buy	$9.00
Sep 22, 2026	Mazahir Alimohamed	Oppenheimer	Reiterates	Buy	$8.00 → $5.00 −3.00 (−37.5%)
Sep 16, 2026	Unknown Analyst	Leerink Partners	Reiterates	Buy	$6.00 → $4.00 −2.00 (−33.3%)
Aug 27, 2026	Julian Harrison	BTIG	Maintains	Buy	$10.00
Aug 13, 2026	Biren Amin	Piper Sandler	Maintains	Buy	$7.00

Unknown Analyst

Leerink Partners

BuyMaintains

$4.00

Oct 12

Brandon Folkes

HC Wainwright

BuyReiterates

$7.00

Oct 8

Brandon Folkes

HC Wainwright

BuyReiterates

$7.00

Oct 2

Edward Nash

Canaccord Genuity

BuyReiterates

$6.00

Oct 1

Thomas Flaten

Lake Street

BuyMaintains

$9.00

Sep 30

Mazahir Alimohamed

Oppenheimer

BuyReiterates

$8.00 → $5.00

Sep 22

Unknown Analyst

Leerink Partners

BuyReiterates

$6.00 → $4.00

Sep 16

Julian Harrison

BTIG

BuyMaintains

$10.00

Aug 27

Biren Amin

Piper Sandler

BuyMaintains

$7.00

Aug 13

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 12, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CNTB?

The analyst consensus rating for CNTB is Buy, based on the latest ratings from 7 analysts over the last 90 days.

What is the average price target for CNTB?

The average 12-month price target for CNTB is $6.86, representing an upside of 656.9% from the Oct 16, 2026 close of $0.91.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.